| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 142.80 | 19.88 | 22.77p | 54.0 | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 139.99 | (45.98) | (41.29)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 89.54 | (188.53) | (163.11)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 128.80 | (47.27) | (41.75)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-25 | 168.74 | (31.94) | (26.92)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Oxford Biomedica inks service deal with Plowshar... | 16-Jul-2026 |
| Oxford Biomedica reiterates full-year guidance, ... | 26-Mar-2026 |
| EQT not planning to bid for Oxford Biomedica | 25-Feb-2026 |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Price | 646.00p |
| Change Today | -3.00p |
| 52 Week High | 913.00p |
| 52 Week Low | 362.50p |
| Volume | 278,386 |
| Shares Issued | 121.04m |
| Market Cap | £781.91m |
| Strong Buy | 4 |
| Buy | 1 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 7 |
